From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture.
about
Fixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products.Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeysProstaglandin pathway gene therapy for sustained reduction of intraocular pressureProlonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates.Bimatoprost in the treatment of eyelash hypotrichosisClinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionProstamides (prostaglandin-ethanolamides) and their pharmacology.Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution.Cellular basis for bimatoprost effects on human conventional outflow.Aqueous humor outflow: dynamics and disease.Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, foOcular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study.Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trialsEndogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility.Ocular surface cytotoxicity and safety evaluation of tafluprost, a recently developed anti-glaucoma prostaglandin analog.Latanoprost in the treatment of glaucoma.Unconventional aqueous humor outflow: A review.Unoprostone reduces oxidative stress- and light-induced retinal cell death, and phagocytotic dysfunction, by activating BK channels.Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea.Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription.Reliable intraocular pressure measurement using automated radio-wave telemetry.Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataractImmunologic corneal graft rejection after administration of topical latanoprost: a report of two patients.In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.Can NSAIDs and prostaglandin analogues be combined?Bimatoprost (0.03%)-induced accommodative spasm and pseudomyopia.Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis.
P2860
Q30588260-D58668E7-D596-4EE1-9053-9A93314C55C2Q33626299-87D697AA-55F5-49F8-9242-72E85CD51A9DQ33731140-F3EEDF23-8AD5-445D-A47A-ADBCA0CCCA0CQ33792019-0702FB70-7100-4CF8-94AB-5A554B88002CQ33819865-04F190D0-8EE4-40BD-AB42-BF3B974B6E7AQ34043309-35CF72B9-152E-4BBB-9669-DB618E270115Q34667670-7A8903BA-C0B7-4FDB-B33C-93114C445935Q34718491-617C67AC-2ECD-442F-AE7E-3E4891EFD0EBQ34735244-061E1F1A-C2E8-4970-8864-0D66DC763F20Q35608780-4FD8983C-DF9E-4CBD-9C0B-5CB561256D32Q36403804-A12F79E7-C3CC-441A-A2BE-6FC882EE7894Q36985297-0417F3B3-A214-44F2-95B6-6EF57D5242C9Q37091331-3D958B96-3614-449D-B6BB-8150218FE1D6Q37452805-2B8A7E60-1EB5-4F4B-AD96-75E7D077DD79Q38190054-EF76B149-412A-4944-A2EE-2CEC11DD4B66Q38261310-2E578BFC-8C63-4D19-B025-4A2D6EC83029Q38724447-61EC0C22-2C35-4618-99DB-A1CEF0D17135Q39417373-85422A96-DCB7-41F5-BA33-9934A0D0577DQ39760193-8AFF9B8A-6054-4160-AAB1-4F9E645FA7E5Q40552681-4A07687D-7C02-4545-94B6-CA6F1985AF8DQ41871242-EB915D08-B2FD-4E3C-8564-2CA9FDA2F72AQ42240928-DC3F93EF-5D98-4183-8E03-940E468E22E1Q42578763-F610FDDD-1933-4506-A3AF-47C7244ACFBFQ42773028-B10DF780-DED8-4BE7-8970-1D8DBE32A9FEQ43208035-3F091DCA-EF7D-4F19-8FE7-DEDC827AF528Q46191748-06D9B219-99A0-4323-874E-6C66A8F8E6D5Q50348514-CA220B99-5952-4E56-BD3D-802E1CFFC31C
P2860
From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
From PGF
@nl
From PGF(2alpha)-isopropyl est ...... xalatan: the Proctor Lecture.
@ast
From PGF(2alpha)-isopropyl est ...... xalatan: the Proctor Lecture.
@en
type
label
From PGF
@nl
From PGF(2alpha)-isopropyl est ...... xalatan: the Proctor Lecture.
@ast
From PGF(2alpha)-isopropyl est ...... xalatan: the Proctor Lecture.
@en
prefLabel
From PGF
@nl
From PGF(2alpha)-isopropyl est ...... xalatan: the Proctor Lecture.
@ast
From PGF(2alpha)-isopropyl est ...... xalatan: the Proctor Lecture.
@en
P1476
From PGF(2alpha)-isopropyl est ...... f xalatan: the Proctor Lecture
@en
P2093
Stjernschantz JW
P304
P407
P577
2001-05-01T00:00:00Z